• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Verdezyne

edit

Verdezyne is a privately-held company that employs its biological expertise and proprietary advanced computational algorithms to design and synthesize novel, high-diversity gene libraries for engineering proteins, metabolic pathways, and microorganisms. The company creates and harnesses this unique biological diversity to optimize commercial fermentation processes for the production of petrochemical replacements.

Recent Milestones

edit

• 
  Verdezyne received () in Venture Round funding. (5/10/11)
  Posted 5/9/11 at 7:42pm via finsmes.com
• 
  Verdezyne received $9M in Venture Round funding. (2/11/10)
  Posted 7/20/10 at 8:04pm via xconomy.com
• 
  Verdezyne received $3M in Venture Round funding. (11/2/09)
  Posted 11/2/09 at 11:52pm via venturebeat.com
• 
  Verdezyne added E. William Radany as President and CEO.
  Posted 7/28/11 at 4:32am
• 
  Verdezyne added Stephen Picataggio as Chief Scientific Officer.
  Posted 7/28/11 at 4:32am
• 
  Verdezyne added Brian Conn as CFO.
  Posted 7/28/11 at 4:32am

Videos

Screenshots

edit

Above: Verdezyne
Uploaded: 11/3/09

Sources

1. Verdezyne raises $3M for organism-made biofuels (deals.venturebeat.com) [edit]
2. Verdezyne Raises $9M (xconomy.com) [edit]
3. Verdezyne Closes Funding Round (finsmes.com) [edit]